What is the name of the MR vaccine released by Indian immunologists to protect children against measles and rubella?a)RubixMb)MeasloGuardc)Immunellad)MabellaCorrect answer is option 'D'. Can you explain this answer?

Question

Answer

The MR vaccine 'Mabella' has been introduced by Indian immunologists to safeguard children from measles and rubella. It is administered in two doses, with the first dose recommended at 9 months and the second dose at 16-24 months of age.

Answer

MR Vaccine released by Indian Immunologists
The MR vaccine released by Indian immunologists to protect children against measles and rubella is called Mabella.

Importance of the MR Vaccine
- The MR vaccine is crucial in preventing measles and rubella, which are highly contagious diseases that can have serious complications, especially in children.
- Measles can lead to severe health issues such as pneumonia, encephalitis, and even death, while rubella can cause birth defects if contracted by pregnant women.

Features of Mabella Vaccine
- Mabella is a combination vaccine that provides protection against both measles and rubella in a single shot.
- The vaccine is safe, effective, and has been approved by Indian regulatory authorities for use in the country.
- It is part of the national immunization program in India, aimed at reducing the burden of these preventable diseases.

Benefits of Mabella Vaccine
- By vaccinating children with Mabella, the spread of measles and rubella can be significantly reduced, leading to a healthier population.
- The vaccine also helps in achieving herd immunity, protecting those who are unable to be vaccinated, such as infants, pregnant women, and individuals with weakened immune systems.
In conclusion, the Mabella vaccine released by Indian immunologists plays a crucial role in protecting children from measles and rubella, thereby contributing to the overall health and well-being of the population.

Answer

Answer

The MR vaccine, which stands for Measles-Rubella vaccine, is a significant public health initiative introduced in India to combat two serious viral diseases: measles and rubella. This vaccine combines protection against both diseases in a single shot, simplifying the immunization process and increasing coverage efficiency.

### Measles
Measles is a highly contagious viral disease characterized by symptoms such as high fever, cough, runny nose, and a distinctive rash that typically starts on the face and spreads. It can lead to severe complications, including pneumonia, encephalitis, and death, especially in malnourished children or those with weakened immune systems.

### Rubella
Rubella, also known as German measles, is generally less severe than measles in children but can have serious consequences if contracted during pregnancy. It can cause congenital rubella syndrome (CRS) in newborns, leading to heart defects, cataracts, and hearing loss. The rubella vaccine is crucial for preventing these birth defects.

### The MR Vaccine
The MR vaccine combines live attenuated strains of both the measles and rubella viruses. Its introduction in India aimed to:

1. **Reduce Disease Incidence:** By providing combined protection against measles and rubella, the vaccine helps in reducing the incidence of these diseases and their complications.

2. **Simplify Immunization:** Combining the vaccines into one shot reduces the number of vaccinations a child needs, making it easier for health programs to deliver and for parents to manage.

3. **Increase Coverage:** With a single vaccine protecting against two diseases, the goal is to increase immunization rates and achieve broader coverage.

### Implementation
India introduced the MR vaccine as part of its national immunization program. The vaccine is typically administered to children between 9 months and 15 years of age, depending on the specific immunization schedule and campaigns. Mass vaccination drives are often conducted to ensure high coverage and help in the effort to eliminate these diseases from the population.

The MR vaccine is a critical tool in improving child health and reducing the incidence of measles and rubella, thereby contributing significantly to public health goals in India and other countries where similar vaccination programs are implemented.

Answer

Developed in partnership with Polyvac Institute of Vietnam, IIL launched Mabella vaccine as part of the 25th celebrations of Human Biologicals Institute. Vaccine maker Indian Immunologicals (IIL) has launched measles and rubella vaccine Mabella for children.

Answer

Meballa

Answer

Mabella option D

Answer

The vaccine developed by Indian immunologist Dr. V.G. Somani to protect children against measles is known as Mabella.
.It is a combination vaccine that protects against both measles and rubella viruses.

Answer

(b)MeasloGuard

Answer

Mabella is the answer.

Top Courses for Bank ExamsView all

Lucent for GK

Current Affairs & Hindu Analysis: Daily, Weekly & Monthly

General Awareness & Knowledge

Tips & Tricks for Government Exams

Improve Your Calculations: Vedic Maths (English)

Top Courses for Bank Exams

Top Courses for Bank Exams

Suggested Free Tests

Related Content

Schools

Competitive Examinations

Quick Access Links

Technical Exams